Alnylam Pharmaceuticals, Inc.ALNYNASDAQ
Loading
Debt Growth Recovery in ProgressRecovering
Percentile Rank8
Year-over-Year Change
Year-over-year debt growth rate
Percentile
P8
Near historical low
vs 5Y Ago
0x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | -2.30% |
| Q3 2025 | -52.24% |
| Q2 2025 | 0.64% |
| Q1 2025 | -0.77% |
| Q4 2024 | 0.63% |
| Q3 2024 | 0.66% |
| Q2 2024 | 0.89% |
| Q1 2024 | 0.06% |
| Q4 2023 | 104.93% |
| Q3 2023 | -0.40% |
| Q2 2023 | -0.46% |
| Q1 2023 | 0.01% |
| Q4 2022 | -0.27% |
| Q3 2022 | 33.59% |
| Q2 2022 | -0.44% |
| Q1 2022 | -0.22% |
| Q4 2021 | 31.19% |
| Q3 2021 | -0.08% |
| Q2 2021 | 46.78% |
| Q1 2021 | -0.51% |
| Q4 2020 | 58.20% |
| Q3 2020 | 4.57% |
| Q2 2020 | 3.36% |
| Q1 2020 | 0.33% |
| Q4 2019 | -0.26% |
| Q3 2019 | -9.49% |
| Q2 2019 | 2.21% |
| Q1 2019 | 997.59% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | -80.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |